$371.90
0.45% today
NYSE, Sep 16, 08:13 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock price

$370.25
+41.26 12.54% 1M
+13.36 3.74% 6M
+70.79 23.64% YTD
+72.93 24.53% 1Y
+99.42 36.71% 3Y
+152.07 69.70% 5Y
+286.85 343.94% 10Y
NYSE, Closing price Fri, Sep 13 2024
+2.46 0.67%
ISIN
US8636671013
Symbol
SYK
Sector

Key metrics

Market capitalization $141.09b
Enterprise Value $151.88b
P/E (TTM) P/E ratio 41.29
EV/FCF (TTM) EV/FCF 54.18
EV/Sales (TTM) EV/Sales 7.10
P/S ratio (TTM) P/S ratio 6.60
P/B ratio (TTM) P/B ratio 7.14
Dividend yield 0.82%
Last dividend (FY23) $3.05
Revenue growth (TTM) Revenue growth 9.94%
Revenue (TTM) Revenue $21.39b
EBIT (operating result TTM) EBIT $4.57b
Free Cash Flow (TTM) Free Cash Flow $2.80b
Cash position $1.96b
EPS (TTM) EPS $8.97
P/E forward 36.59
P/S forward 6.30
EV/Sales forward 6.79
Short interest 1.23%
Show more

Is Stryker a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Stryker Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Stryker forecast:

22x Buy
67%
10x Hold
30%
1x Sell
3%

Analyst Opinions

33 Analysts have issued a Stryker forecast:

Buy
67%
Hold
30%
Sell
3%

Financial data from Stryker

Jun '24
+/-
%
Net Profit 3,448 3,448
27% 27%
16%
Depreciation and Amortization 1,030 1,030
1% 1%
5%
Stock Compensation 225 225
29% 29%
1%
Operating Cash Flow 3,415 3,415
13% 13%
16%
Investments 612 612
1% 1%
3%
Dividend Paid 1,179 1,179
8% 8%
6%
Free Cash Flow 2,803 2,803
16% 16%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Stryker directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Stryker Stock News

Neutral
PRNewsWire
4 days ago
EMERYVILLE, Calif. , Sept. 12, 2024 /PRNewswire/ -- Eko Health , a pioneer in applying artificial intelligence (AI) for early detection of heart and lung diseases, today announced the appointment of Brent D.
Neutral
Seeking Alpha
10 days ago
Stryker Corporation (NYSE:SYK ) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 3:00 PM ET Company Participants Spencer Stiles - Group President, Orthopedics and Spine Jason Beach - Vice President, Investor Relations Conference Call Participants Larry Biegelsen - Wells Fargo All right, welcome back. I'm Larry Biegelsen, the medical device analyst at Wells Fargo.
Neutral
GlobeNewsWire
25 days ago
Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.
More Stryker News

Company Profile

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Head office United States
CEO Kevin Lobo
Employees 52,000
Founded 1941
Website www.stryker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today